Competition Council investigates possible abuse of dominant position in pharmaceutical market
Consiliul Concurenței investighează un posibil abuz de poziție dominantă pe piața farmaceutică
Our Take
Merck Sharp Dohme faces formal abuse probe in Romania; pharma leaders should audit pricing, supply, and licensing terms against EU precedent now.